Abstract: The present invention relates to novel stable compressed vaccine composition comprising at least one anhydrous antigenic component comprising a stabilizer susceptible to foaming when the composition is mixed with liquid diluent; and an effective amount of a sugar alcohol.

Abstract: There is provided a system and methods for identifying an optimised internet connectivity configuration. The system comprises a processing module configured to process received data and a processor that calculates outcome values for each of a plurality of indicators associated with in-flight internet connectivity. Each outcome value is calculated using received data, a trained machine learning model, and a set of features associated with the corresponding indicator. The calculated set of outcome values are used to identify a recommended one of a number of internet connectivity configurations that are each associated with a characteristic set of outcome values.

Abstract: The present invention relates generally to the fields of immunology and vaccine technology. More specifically, the present invention relates to stabilized liquid immunogenic compositions and vaccines having a live attenuated viral antigen, and methods of using the same. The live attenuated viral antigen can be a live peste des petits ruminants (PPR) virus.

Abstract: A device for protecting a mobile or static structure against the blast from an explosion or detonation and associated projections of material. The device includes a protective casing made of several materials, the protective casing being located at a distance from the structure to be protected and connected to the structure by an elastomer connection. The protective casing is elastically deformable so as to be able to deform elastically for the duration of the stress by oscillating to spread the energy of the blast from the explosion over its surface and over time in several directions, and then to return completely or partially to its original shape after a period of time.

Abstract: The present invention relates to novel stable compressed vaccine composition comprising at least one anhydrous antigenic component comprising a stabilizer susceptible to foaming when the composition is mixed with liquid diluent; and an effective amount of a sugar alcohol.

Abstract: The present invention relates generally to the fields of immunology and vaccine technology. More specifically, the present invention relates to stabilized liquid immunogenic compositions and vaccines having a live attenuated viral antigen, and methods of using the same. The live attenuated viral antigen can be a live peste des petits ruminants (PPR) virus.

Abstract: The present invention relates to novel stable compressed vaccine composition comprising at least one anhydrous antigenic component comprising a stabilizer susceptible to foaming when the composition is mixed with liquid diluent; and an effective amount of a sugar alcohol.

Abstract: The present invention relates generally to the fields of immunology and vaccine technology. More specifically, the present invention relates to methods for vitrifying biological preparations, including peptides, antigens, antibodies, cells, and the like.

Abstract: The present invention relates generally to the fields of immunology and vaccine technology. More specifically, the present invention relates to methods for freeze-drying biological preparations, including peptides, antigens, antibodies, and especially, cells. Importantly, the disclosed methods preserve the viability, infectivity and immunogenicity of cells from the Apicomplexa phylum, the Sarcocystidae family, and in particular, cells from the Toxoplasma genus.

Abstract: Disclosed and claimed are methods for making solid vaccine compositions that have reduced foaming when mixed with liquid diluent. The methods include mixing an effective amount of a foam controlling agent with at least one anhydrous antigenic component, a stabilizer, and an effervescent agent. The foam controlling agent is a sugar alcohol, such as mannitol. The effective amount of sugar alcohol is about 15% to about 40% by weight of the solid vaccine composition. And, upon adding a diluent to the solid vaccine composition, the effervescent agent reacts to form gas in situ, and foam resulting from the gas is reduced.

Abstract: The present invention relates to novel stable compressed vaccine composition composing at least one anhydrous antigenic component comprising a stabilizer susceptible to foaming when the composition is mixed with liquid diluent; and an effective amount of a sugar alcohol.

Abstract: The present invention relates generally to the fields of immunology and vaccine technology. More specifically, the present invention relates to methods for vitrifying biological preparations, including peptides, antigens, antibodies, cells, and the like.

Abstract: The present invention relates to novel stable compressed vaccine composition comprising at least one anhydrous antigenic component comprising a stabilizer susceptible to foaming when the composition is mixed with liquid diluent; and an effective amount of a sugar alcohol.

Abstract: The present invention relates to novel stable compressed vaccine composition comprising at least one anhydrous antigenic component comprising a stabilizer susceptible to foaming when the composition is mixed with liquid diluent; and an effective amount of a sugar alcohol.

Abstract: The present invention relates to novel stable compressed vaccine composition comprising least one anhydrous antigenic component comprising a stabilizer susceptible to foaming when the composition is mixed with liquid diluent; and an effective amount of a sugar alcohol.

Abstract: The present invention relates generally to the fields of immunology and vaccine technology. More specifically, the present invention relates to methods for vitrifying biological preparations, including peptides, antigens, antibodies, cells, and the like.

Abstract: The present invention relates generally to the fields of immunology and vaccine technology. More specifically, the present invention relates to methods for freeze-drying biological preparations, including peptides, antigens, antibodies, and especially, cells. Importantly, the disclosed methods preserve the viability, infectivity and immunogenicity of cells from the Apicomplexa phylum, the Sarcocystidae family, and in particular, cells from the Toxoplasma genus.

Abstract: The present invention relates to novel stable compressed vaccine composition comprising at least one anhydrous antigenic component comprising a stabilizer susceptible to foaming when the composition is mixed with liquid diluent; and an effective amount of a sugar alcohol.

Abstract: A system monitors and controls pressure of vehicle parts. The system consists of: a fleet of vehicles, each vehicle of the fleet having a cab and a trailer; a controller maintaining a wireless server and database for the fleet of vehicles; a first cellular device transmitting data to and from an electronic control unit of the cab of each vehicle and the controller; and a second cellular device transmitting data to and from an electronic control unit of the trailer of each vehicle and the controller. The first cellular device and the second cellular device each utilize a publicly accessible cellular network for communication with the controller.

Abstract: A system monitors and controls pressure of vehicle parts. The system consists of: a fleet of vehicles, each vehicle of the fleet having a cab and a trailer; a controller maintaining a wireless server and database for the fleet of vehicles; a first cellular device transmitting data to and from an electronic control unit of the cab of each vehicle and the controller; and a second cellular device transmitting data to and from an electronic control unit of the trailer of each vehicle and the controller. The first cellular device and the second cellular device each utilize a publicly accessible cellular network for communication with the controller.